Answers are grounded in this paper and cite their sources.
Postherpetic neuralgia (PHN) is a common and debilitating complication of herpes zoster (HZ), but how metabolism changes during progression from HZ to PHN is still poorly understood. In this study, we used untargeted metabolomics to compare serum metabolite profiles among 65 HZ patients, 38 PHN patients, and 86 healthy controls from Sichuan Province, China. In patients with HZ relative to controls, we found elevated levels of pyruvic, glutamic, hydroxypyruvic, glyoxylic, and ketobutyric acids, along with decreased arginine and citrulline. Enrichment analysis pointed to changes in the urea cycle and in glycine, serine, and alanine metabolism. When we compared PHN patients with HZ patients, the former showed higher homocysteine, choline, argininosuccinic acid, 1-pyrroline-5-carboxylic acid, and citrulline, as well as lower β-alanine; pathway analysis indicated alterations in betaine, arginine, proline, methionine, glycine, and serine metabolism. Using repeated nested cross-validation, multi-metabolite models robustly distinguished HZ from healthy controls (AUC, 0.979), whereas discrimination between PHN and HZ was substantially weaker (AUC, 0.678). This pattern points to a qualitative shift in metabolic state during progression to PHN rather than a simple worsening of the HZ-associated profile. Taken together, these metabolomic data provide new leads for understanding HZ and PHN pathophysiology and may help identify biomarkers for clinical use.
No takes yet. Share an insight, caveat, or question.
Du et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: